Lucid Diagnostics Inc. (LUCD) vs Unicycive Therapeutics, Inc. (UNCY)
A side-by-side comparison of Lucid Diagnostics Inc. and Unicycive Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
LUCD
Lucid Diagnostics Inc.
$0.60HealthcareDelayed quote: Oct 6, 2026, 3:20 PM EDT
UNCY
Unicycive Therapeutics, Inc.
$4.21HealthcareDelayed quote: Oct 6, 2026, 3:15 PM EDT
Total return — LUCD vs UNCY
growth of $100 · dividends reinvested · last 5yLUCD -95.0% (-45.0%/yr)UNCY -84.7% (-31.3%/yr)UNCY compounded faster over this window
LUCD UNCY
LUCD vs UNCY: by the numbers
- •LUCD is the larger company ($114M vs $112M market cap).
- •Both run net losses; UNCY's is the smaller (0.00% vs -959.76% net margin).
Metrics side by side
Valuation
| Metric | LUCD | UNCY |
|---|---|---|
| P/S ratio | 21.01 | N/A |
| P/B ratio | 10.47 | 2.11 |
Profitability
| Metric | LUCD | UNCY |
|---|---|---|
| Gross margin | -60.26% | 0.00% |
| Operating margin | -1054.82% | 0.00% |
| Net margin | -959.76% | 0.00% |
| ROE | -478.26% | -66.12% |
| ROIC | -145.10% | -62.15% |
Growth (annualized)
| Metric | LUCD | UNCY |
|---|---|---|
| Total return CAGR (5Y) | N/A | -32.14% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.